ID:2043 Response to a 2-Indolinones laboratory based regimen analogous in cancerous-infected cells. Biomedical Research and Therapy, [S. l.], v. 4, n. S, p. S74-S75, 2017. DOI: 10.15419/bmrat.v4iS.280. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/280.. Acesso em: 15 nov. 2024.